GeneDx Holdings (WGS) Operating Leases (2022 - 2026)

GeneDx Holdings (WGS) has reported Operating Leases for 5 consecutive years, with $64.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Leases rose 8.79% year-over-year to $64.9 million in Q2 2026; TTM through Jun 2026 was $64.9 million, a 8.79% increase from a year earlier, with the FY2025 full-year figure at $56.0 million, down 12.78% from the prior year.
• Operating Leases was $64.9 million for Q2 2026 at GeneDx Holdings, down from $66.3 million in the prior quarter.
• Over five years, Operating Leases peaked at $69.1 million in Q2 2023 and troughed at $56.0 million in Q4 2025.
• A 5-year average of $63.7 million and a median of $64.1 million in 2023 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases decreased 12.78% in 2025 and increased 10.7% in 2026, its largest moves.
• Over 5 years, Operating Leases stood at $66.1 million in 2022, then increased by 0.68% to $66.6 million in 2023, then decreased by 3.5% to $64.3 million in 2024, then fell by 12.78% to $56.0 million in 2025, then climbed by 15.72% to $64.9 million in 2026.
• The last three Operating Leases figures came in at $64.9 million (Q2 2026), $66.3 million (Q1 2026), and $56.0 million (Q4 2025), per Business Quant data.